
    
      This is a Phase â…¡ exploratory clinical study. The purpose of this study is to evaluate the
      efficacy and safety of recombinant anti-tumor and anti-virus protein for injection plus
      capecitabine in treating patients with metastatic colorectal cancer who have progressed after
      standard therapy.

      All patients will receive recombinant anti-tumor and anti-virus protein for injection and
      capecitabine.
    
  